Chronic Spinal Cord Injury
12
4
4
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
NVG-291 in Spinal Cord Injury Subjects
RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation
Abdominal Electrical Stimulation for Bowel Dysfunction in SCI
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
AXER-204 in Participants With Chronic Spinal Cord Injury
LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury
The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury
Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation
Impact of Persistent Conductances on Motor Unit Firing in SCI
Cell Transplant in Spinal Cord Injury Patients